1.Probable Molecular Targeting of Inhibitory Effect of Carvacrol-Loaded Bovine Serum Albumin Nanoparticles on Human Breast Adenocarcinoma Cells.
Pouria KHODAVANDI ; Neda KARAMI ; Alireza KHODAVANDI ; Fahimeh ALIZADEH ; Esmaeel Panahi KOKHDAN ; Ahmad ZAHERI
Chinese journal of integrative medicine 2025;31(4):336-346
OBJECTIVE:
To entrap carvacrol (CAR) in bovine serum albumin nanoparticles (BSANPs) to form CAR-loaded BSANPs (CAR@BSANPs) and to explore the anti-cancer effects in breast adenocarcinoma cells (MCF-7 cells) treated with CAR and CAR@BSANPs.
METHODS:
A desolvation method was used to synthesize BSANPs and CAR@BSANPs. The BSANPs and CAR@BSANPs were characterized by several physicochemical methods, including visual observation, high-resolution field emission scanning electron microscopy, Fourier transform infrared spectroscopy, and high-performance liquid chromatography. MCF-7 cells were used and analyzed after 24 h of exposure to CAR and CAR@BSANPs at half-maximal inhibitory concentration. The anti-proliferative, apoptotic, reactive oxygen species (ROS), and nitric oxide (NO) scavenging activity as well as gene expression analysis were investigated by the cell viability assay, phase-contrast microscopy, 2',7'-dichlorofluorescein-diacetate assay, Griess-Illosvoy colorimetric assay, and quantitative real-time polymerase chain reaction, respectively.
RESULTS:
CAR and CAR@BSANPs showed anti-proliferative, apoptotic, ROS generation, and NO scavenging effects on MCF-7 cells. Expression profile of B-cell lymphoma 2-like 11 (BCL2L11), vascular endothelial growth factor A (VEGFA), hypoxia inducible factor factor-1α (HIF1A), BCL2L11/apoptosis regulator (BAX), and BCL2L11/Bcl2 homologous antagonist/killer 1 (BAK1) ratios revealed downregulated genes; and BAX, BAK1, and CASP8 were upregulated by CAR and CAR@BSANPs treatment. In vitro anticancer assays of the CAR and CAR@BSANPs showed that CAR@BSANPs demonstrated higher therapeutic efficacy in the MCF-7 cells than CAR.
CONCLUSIONS
CAR and CAR@BSANPs affect gene expression and may subsequently reduce the growth and proliferation of the MCF-7 cells. Molecular targeting of regulatory genes of the MCF-7 cells with CAR and CAR@BSANPs may be an effective therapeutic strategy against breast cancer.
Humans
;
Cymenes
;
Nanoparticles/ultrastructure*
;
MCF-7 Cells
;
Breast Neoplasms/genetics*
;
Apoptosis/drug effects*
;
Serum Albumin, Bovine/chemistry*
;
Monoterpenes/therapeutic use*
;
Adenocarcinoma/genetics*
;
Cell Proliferation/drug effects*
;
Reactive Oxygen Species/metabolism*
;
Female
;
Cell Survival/drug effects*
;
Animals
;
Gene Expression Regulation, Neoplastic/drug effects*
;
Nitric Oxide/metabolism*
;
Cattle

Result Analysis
Print
Save
E-mail